Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W3028060764', 'doi': 'https://doi.org/10.1691/ph.2020.0316', 'title': 'Effects of cyclosporin A on the pharmacokinetics and toxicities of irinotecan mediated by UGT1A1 in vitro and in vivo.', 'display_name': 'Effects of cyclosporin A on the pharmacokinetics and toxicities of irinotecan mediated by UGT1A1 in vitro and in vivo.', 'publication_year': 2020, 'publication_date': '2020-05-01', 'ids': {'openalex': 'https://openalex.org/W3028060764', 'doi': 'https://doi.org/10.1691/ph.2020.0316', 'mag': '3028060764', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/32393425'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/32393425', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.333824, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 60, 'max': 69}, 'biblio': {'volume': '75', 'issue': '5', 'first_page': '186', 'last_page': '190'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13160', 'display_name': 'Synthesis and Biological Evaluation', 'score': 0.9118, 'subfield': {'id': 'https://openalex.org/subfields/1605', 'display_name': 'Organic Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2780259306', 'wikidata': 'https://www.wikidata.org/wiki/Q412197', 'display_name': 'Irinotecan', 'level': 4, 'score': 0.91470826}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.8102192}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.8023627}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.76666355}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.6024287}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4187129}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.37972605}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.18673989}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.15425879}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.12220359}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.101986945}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.051561713}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D016572', 'descriptor_name': 'Cyclosporine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014453', 'descriptor_name': 'Glucuronosyltransferase', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000077146', 'descriptor_name': 'Irinotecan', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D059004', 'descriptor_name': 'Topoisomerase I Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019540', 'descriptor_name': 'Area Under Curve', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016572', 'descriptor_name': 'Cyclosporine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D016572', 'descriptor_name': 'Cyclosporine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003967', 'descriptor_name': 'Diarrhea', 'qualifier_ui': 'Q000139', 'qualifier_name': 'chemically induced', 'is_major_topic': False}, {'descriptor_ui': 'D003967', 'descriptor_name': 'Diarrhea', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014453', 'descriptor_name': 'Glucuronosyltransferase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007166', 'descriptor_name': 'Immunosuppressive Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D007166', 'descriptor_name': 'Immunosuppressive Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D007166', 'descriptor_name': 'Immunosuppressive Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020128', 'descriptor_name': 'Inhibitory Concentration 50', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077146', 'descriptor_name': 'Irinotecan', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000077146', 'descriptor_name': 'Irinotecan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008862', 'descriptor_name': 'Microsomes, Liver', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D008862', 'descriptor_name': 'Microsomes, Liver', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017207', 'descriptor_name': 'Rats, Sprague-Dawley', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D059004', 'descriptor_name': 'Topoisomerase I Inhibitors', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D059004', 'descriptor_name': 'Topoisomerase I Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/32393425', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.8, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3038505084', 'https://openalex.org/W3028060764', 'https://openalex.org/W2550413855', 'https://openalex.org/W2434195791', 'https://openalex.org/W2409285845', 'https://openalex.org/W2138350991', 'https://openalex.org/W2054843986', 'https://openalex.org/W1994342570', 'https://openalex.org/W1940591674', 'https://openalex.org/W1566729005'], 'abstract_inverted_index': {'Irinotecan': [0], '(CPT-11)': [1], 'is': [2, 17], 'a': [3, 105, 233], 'broad': [4], 'spectrum': [5], 'agent': [6], 'for': [7, 36, 148, 188], 'the': [8, 28, 37, 63, 74, 83, 91, 134, 151, 179, 184, 195, 214, 223, 237], 'treatment': [9, 93, 143, 211, 243], 'of': [10, 25, 66, 76, 109, 127, 154, 186, 219, 228, 239], 'solid': [11], 'tumor': [12], 'malignancies,': [13], 'despite': [14], 'severe': [15], 'diarrhea': [16], 'limiting': [18], 'its': [19, 89, 112, 157], 'widespread': [20], 'usage.': [21], 'The': [22, 164, 205, 226], 'local': [23], 'effects': [24], 'SN-38': [26, 128, 220], 'in': [27, 57, 94, 137, 140, 175, 236], 'small': [29], 'intestine': [30], 'were': [31, 202], 'considered': [32], 'to': [33, 104, 129], 'be': [34, 232], 'responsible': [35], 'irinotecan-induced': [38, 119], 'delayed': [39], 'diarrhea.': [40], 'It': [41], 'was': [42, 102, 115, 168, 191], 'proposed': [43], 'that': [44, 174, 209], 'cyclosporin': [45, 80], 'A': [46, 81], '(CsA)': [47], 'inhibiting': [48, 222], 'biliary': [49], 'excretion': [50, 78, 153], 'could': [51, 60, 212], 'attenuate': [52], 'this': [53], 'side': [54], 'effect,': [55], 'but': [56], 'fact,': [58], 'it': [59], 'not': [61], 'improve': [62], 'therapeutic': [64], 'index': [65], 'irinotecan.': [67], 'At': [68], 'present,': [69], 'most': [70], 'studies': [71], 'focused': [72, 123], 'on': [73, 124], 'inhibition': [75, 227], 'bile': [77, 152], 'by': [79, 221], 'through': [82], 'transporters': [84], 'MRP2': [85], 'and': [86, 88, 111, 114, 131, 139, 156, 160, 198, 217], 'MDR1': [87], 'effect': [90], 'irinotecan': [92, 110, 155], 'vivo.': [95, 141], 'However,': [96], 'UDP': [97], 'glucuronyltransferase-1': [98], 'polypeptide': [99], 'A1': [100], '(UGT1A1)': [101], 'related': [103], 'significantly': [106, 169, 203], 'altered': [107], 'disposition': [108], 'metabolites,': [113], 'therefore': [116], 'associated': [117], 'with': [118, 144, 173], 'toxicity.': [120], 'This': [121], 'study': [122, 207], 'UGT1A1-mediated': [125], 'conversion': [126], 'SN-38G,': [130], 'systematically': [132], 'investigated': [133], 'CsA-irinotecan': [135], 'interactions': [136], 'vitro': [138], 'After': [142], '10': [145], 'mg·kg-1': [146], 'CsA': [147, 187, 210, 240], '7': [149], 'days,': [150], 'metabolites': [158], 'decreased': [159], 'AUC0-∞': [161, 165], 'increased': [162], 'significantly.': [163], '(SN-38G)/AUC0-∞': [166], '(SN-38)': [167], 'reduced': [170], 'when': [171], 'compared': [172], 'vehicle-treated': [176], 'rats.': [177], 'In': [178], 'liver': [180], 'microsome': [181], 'incubation': [182], 'system,': [183], 'IC50': [185], 'UGT1A1': [189, 196, 224, 229], 'enzyme': [190, 230], '9.4': [192], 'μM.': [193], 'Furthermore,': [194], 'mRNA': [197], 'protein': [199], 'expression': [200], 'levels': [201], 'reduced.': [204], 'present': [206], 'indicated': [208], 'enhance': [213], 'systemic': [215], 'exposure': [216], 'toxicity': [218], 'enzyme.': [225], 'might': [231], 'critical': [234], 'factor': [235], 'failure': [238], 'improving': [241], "irinotecan's": [242], 'index.': [244]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3028060764', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}], 'updated_date': '2024-12-26T00:05:12.604673', 'created_date': '2020-05-29'}